# IW-6463 Safety Study in Healthy Elderly Subjects

> **NCT04240158** · PHASE1 · TERMINATED · sponsor: **Tisento Therapeutics** · enrollment: 24 (actual)

## Conditions studied

- Other

## Interventions

- **DRUG:** IW-6463
- **DRUG:** Matching Placebo

## Key facts

- **NCT ID:** NCT04240158
- **Lead sponsor:** Tisento Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-01-06
- **Primary completion:** 2020-05-22
- **Final completion:** 2020-05-22
- **Target enrollment:** 24 (ACTUAL)
- **Why stopped:** Some subjects could not complete the second crossover period due to COVID-19-related site closure. The study was closed to allow analysis of all collected data.
- **Last updated:** 2024-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04240158

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04240158, "IW-6463 Safety Study in Healthy Elderly Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04240158. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*